GlobeNewswire
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
📊
AI Sentiment
Positive
6/10
- Home
- ALGS
as of 12-15-2025 2:48pm EST
$12.11
$1.19
-8.95%
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
Chart Type:
Time Range:
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 57.2M | IPO Year: | 2020 |
| Target Price: | $60.00 | AVG Volume (30 days): | 81.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.76 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.76 - $46.80 | Next Earning Date: | 11-06-2025 |
| Revenue: | $2,646,000 | Revenue Growth: | -55.88% |
| Revenue Growth (this year): | -30.7% | Revenue Growth (next year): | -20.70% |
AI-Powered ALGS Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 71.52%
71.52%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Aligos Therapeutics Inc. News
ALGS Breaking Stock News: Dive into ALGS Ticker-Specific Updates for Smart Investing
GlobeNewswire
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
📈
AI Sentiment
Highly Positive
9/10
Compare ALGS vs Leading Stocks
See how ALGS stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ALGS Aligos Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.